Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Moore Kuehn Encourages AMED, KLR, SGTX, and WAKE Investors to Contact Law Firm

AMED

NEW YORK, July 5, 2023 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies.

(PRNewsfoto/Moore Kuehn, PLLC)

Moore Kuehn is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process:

  • Amedisys, Inc. (NASDAQ: AMED)

Amedisys has agreed to merge with Optum. Under the proposed transaction, Amedisys shareholders will receive $101.00 in cash per share.

  • Kaleyra, Inc. (NYSE: KLR)

Kaleyra has agreed to merge with Tata Communications. Under the proposed transaction, Kaleyra shareholders will receive $7.25 in cash per share.

  • Sigilon Therapeutics, Inc. (NASDAQ: SGTX)

Sigilon Therapeutics has agreed to merge with Eli Lilly. Under the proposed transaction, Sigilon shareholders will receive $14.92 per share in cash.

  • Wake Forest Bancshares (OTC: WAKE)

Wake Forest Bancshares has agreed to merge with Piedmont Federal. Under the proposed transaction, Wake Forest Bancshares shareholders will receive $34.34 in cash per share.

Moore Kuehn encourages shareholders who would like to discuss their rights to contact Justin Kuehn, Esq. by email at jkuehn@moorekuehn.com. The consultation and case are free with no obligation to you. Moore Kuehn pays all case costs and does not charge its investor clients.Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

Moore Kuehn is a 5-star Google client-rated New York City law firm with attorneys representing investors and consumers in litigation involving securities laws, fraud, breaches of fiduciary duties, and other claims. For additional information about Moore Kuehn, please visit http://www.moorekuehn.com/practice/new-york-securities-litigation/.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Moore Kuehn, PLLC
Justin Kuehn, Esq.
30 Wall Street, 8th Floor
New York, New York 10005
jkuehn@moorekuehn.com
(212) 709-8245

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/moore-kuehn-encourages-amed-klr-sgtx-and-wake-investors-to-contact-law-firm-301870350.html

SOURCE Moore Kuehn, PLLC